title: Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling.
abstract: The calcium-activated chloride channel anoctamin 1 (ANO1) is located within the 11q13 amplicon, one of the most frequently amplified chromosomal regions in human cancer, but its functional role in tumorigenesis has remained unclear. The 11q13 region is amplified in ∼15% of breast cancers. Whether ANO1 is amplified in breast tumors, the extent to which gene amplification contributes to ANO1 overexpression, and whether overexpression of ANO1 is important for tumor maintenance have remained unknown. We have found that ANO1 is amplified and highly expressed in breast cancer cell lines and primary tumors. Amplification of ANO1 correlated with disease grade and poor prognosis. Knockdown of ANO1 in ANO1-amplified breast cancer cell lines and other cancers bearing 11q13 amplification inhibited proliferation, induced apoptosis, and reduced tumor growth in established cancer xenografts. Moreover, ANO1 chloride channel activity was important for cell viability. Mechanistically, ANO1 knockdown or pharmacological inhibition of its chloride-channel activity reduced EGF receptor (EGFR) and calmodulin-dependent protein kinase II (CAMKII) signaling, which subsequently attenuated AKT, v-src sarcoma viral oncogene homolog (SRC), and extracellular signal-regulated kinase (ERK) activation in vitro and in vivo. Our results highlight the involvement of the ANO1 chloride channel in tumor progression and provide insights into oncogenic signaling in human cancers with 11q13 amplification, thereby establishing ANO1 as a promising target for therapy in these highly prevalent tumor types.
authors: Friedrich Miescher Institute for Biomedical Research, CH-4058 Basel, Switzerland.
authors: Adrian
authors: A
authors: Britschgi
authors: Anke
authors: A
authors: Bill
authors: Heike
authors: H
authors: Brinkhaus
authors: Christopher
authors: C
authors: Rothwell
authors: Ieuan
authors: I
authors: Clay
authors: Stephan
authors: S
authors: Duss
authors: Michael
authors: M
authors: Rebhan
authors: Pichai
authors: P
authors: Raman
authors: Chantale T
authors: CT
authors: Guy
authors: Kristie
authors: K
authors: Wetzel
authors: Elizabeth
authors: E
authors: George
authors: M Oana
authors: MO
authors: Popa
authors: Sarah
authors: S
authors: Lilley
authors: Hedaythul
authors: H
authors: Choudhury
authors: Martin
authors: M
authors: Gosling
authors: Louis
authors: L
authors: Wang
authors: Stephanie
authors: S
authors: Fitzgerald
authors: Jason
authors: J
authors: Borawski
authors: Jonathan
authors: J
authors: Baffoe
authors: Mark
authors: M
authors: Labow
authors: L Alex
authors: LA
authors: Gaither
authors: Mohamed
authors: M
authors: Bentires-Alj
mesh_terms: D000818:Animals; D000075369:Anoctamin-1; D017209:Apoptosis / Q000235:genetics; D001943:Breast Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2 / Q000235:genetics / Q000378:metabolism*; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000235:genetics; D018118:Chloride Channels / Q000235:genetics / Q000378:metabolism*; D002880:Chromosomes, Human, Pair 11 / Q000235:genetics / Q000378:metabolism*; D004789:Enzyme Activation / Q000235:genetics; D066246:ErbB Receptors / Q000235:genetics / Q000378:metabolism; D005260:Female; D005784:Gene Amplification; D055785:Gene Knockdown Techniques; D006801:Humans; D051379:Mice; D016688:Mice, Inbred NOD; D016513:Mice, SCID; D009363:Neoplasm Proteins / Q000235:genetics / Q000378:metabolism*; D009368:Neoplasm Transplantation; D015398:Signal Transduction / Q000235:genetics; D014183:Transplantation, Heterologous
chemical_list: C476213:ANO1 protein, human; D000075369:Anoctamin-1; D018118:Chloride Channels; D009363:Neoplasm Proteins; C512478:EGFR protein, human; D066246:ErbB Receptors; D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2